Fear-potentiated startle response is remarkably similar in two laboratories

Psychopharmacology

Volumn 126, Issue 2, 1996, Pages 104-109

  Joordens, R J E ^a   Hijzen, T H ^a   Peeters, B W M M ^b   Olivier, B ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b NV ORGANON   (Netherlands)

Author keywords

Anxiety; Fear potentiated startle response; Flesinoxan; Fluvoxamine; Oxazepam; Predictive validity; Reliability; Strychnine potentiated startle response

Indexed keywords

ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; CHLORDIAZEPOXIDE; FLESINOXAN; FLUVOXAMINE; OXAZEPAM; STRYCHNINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DEVICE; FEAR; INTRAPERITONEAL DRUG ADMINISTRATION; LABORATORY; MALE; METHODOLOGY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT; STARTLE REFLEX; TRANQUILIZING ACTIVITY;

ANIMALS; ANTI-ANXIETY AGENTS; CHLORDIAZEPOXIDE; DOSE-RESPONSE RELATIONSHIP, DRUG; FEAR; FLUVOXAMINE; MALE; OXAZEPAM; PIPERAZINES; RATS; RATS, WISTAR; STARTLE REACTION;

EID: 0030055061     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02246344     Document Type: Article

References (22)

1. Berg WK, Davis M (1984) Diazepam blocks fear-enhanced startle elicited electrically from the brainstem. Physiol Behav 32: 333-336
2. 3 receptor antagonist, in two animal models of anxiety. Eur J Pharmacol 218: 327-334
3. Borszcz GS, Cranney J, Leaton RN (1989) Influence of long-term sensitization on long-term habituation of the acoustic startle response in rats: central grey lesions, preexposure, and extinction. J Exp Psychol [Anim Behav Proc] 15: 54-64
4. Davis M (1979a) Diazepam and flurazepam: effects on conditioned fear as measured with the potentiated startle paradigm. Psychopharmacology 62: 1-7
5. Davis M (1979b) Morphine and naloxone: effects on conditioned fear as measured with the potentiated startle paradigm. Eur J Pharmacol 54: 341-347
6. Davis M (1988) Apomorphine, d-amphetamine, strychnine and yohimbine do not alter prepulse inhibition of the acoustic startle reflex, Psychopharmacology 95: 151-156
7. Davis M, Cassella JV, Kehne JH (1988) Serotonin does not mediate anxiolytic effects of buspirone in the fear-potentiated startle paradigm: comparison with 8-OH-DPAT and ipsapirone. Psychopharmacology 94: 14-20
8. Davis M, Redmond DE Jr, Baraban JM (1979) Noradrenergic agonists and antagonists: effects on conditioned fear as measured by the potentiated startle paradigm. Psychopharmacology 65: 111-118
9. Davis M, Falls WA, Campeau S, Kim M (1993) Fear-potentiated startle: a neural and pharmacological analysis. Behav Brain Res 58: 175-198
10. Frankland PW, Yeomans JS (1995) Fear-potentiated startle and electrically evoked startle mediated by synapses in rostrolateral midbrain. Behav Neurosci 109 : 669-680
11. 1A receptor agonist, are not related to its neuroendocrine effects. Eur J Pharmacol 280: 185-193
12. Hijzen TH, Slangen JL (1989) Effects of midazolam, DMCM and lindane on potentiated startle in the rat. Psychopharmacology 99: 362-365
13. Hijzen TH, Houtzager SWJ, Joordens RJE, Olivier B, Slangen JL (1995) Predictive validity of the potentiated startle response as a behavioral model for anxiolytic drugs. Psychopharmacology 118: 150-154
14. Kehne JH, Cassella JV, Davis M (1988) Anxiolytic effects of buspirone and gepirone in the fear-potentiated startle paradigm. Psychopharmacology 94 : 8-13
15. Kehne JH, McCloskey TC, Taylor VL, Black CK, Fadayel GM, Schmidt CJ (1992) Effects of the serotonin releasers 3,4-methylenedioxymethamphetamine (MDMA), 4-chloroamphetamine (PCA) and fenfluramine on acoustic and tactile startle reflexes in rats. J Pharmacol Exp Ther 260: 78-89
16. 1A receptor ligands. Eur J Pharmacol 156: 375-383
17. Mansbach RS, Geyer MA, Braff DL (1988) Dopaminergic stimulation disrupts sensorimotor gating in the rat. Psychopharmacology 94: 507-514
18. Molewijk HE, Van der Poel AM, Mos J, Van Heyden JAM, Olivier B (1995) Conditioned ultrasonic distress vocalizations in adult male rats as a behavioural paradigm for screening anti-panic drugs. Psychopharmacology 117 : 32-40
19. Mos J, Olivier B (1989) Ultrasonic vocalizations by rat pups as an animal model for anxiolytic activity: effects of serotonergic drugs. In: Bevan P, Cools AR, Archer T (eds) Behavioural pharmacology of 5-HT. Lawrence Erlbaum Associates, New Jersey, pp 361-369
20. 3 receptor can reduce the fear-potentiated startle response in the rat: evidence for different types of anxiolytic activity? J Pharmacol Exp Ther 268: 248-254
21. Olivier B, Bosch L, Van Hest A, Van der Heyden J, Mos J, Van der Poel G, Schipper J, Tulp M (1993) Preclinical evidence on the psychotropic profile of fluvoxamine. Pharmacopsychiatry 26: 2-9
22. Swerdlow NR, Britton KT (1994) Alphaxalone, a steroid anesthetic, inhibits the startle-enhancing effects of corticotropin releasing factor, but not strychnine. Psychopharmacology 115: 141-146